Aisap
1 known investors
AISAP develops an FDA-cleared, AI-powered platform for point-of-care ultrasound (POCUS) that delivers expert-level diagnostic results at the bedside. Its tools support clinicians in shortening diagnosis time, reducing length of stay, detecting structural heart disease early, and avoiding unnecessary patient transfers.
AI & Machine LearningDigital HealthMedical Devices
Investors · 1
Frequently asked questions
- What does Aisap do?
- AISAP develops an FDA-cleared, AI-powered platform for point-of-care ultrasound (POCUS) that delivers expert-level diagnostic results at the bedside. Its tools support clinicians in shortening diagnosis time, reducing length of stay, detecting structural heart disease early, and avoiding unnecessary patient transfers.
- Who are Aisap's investors?
- Aisap's investors include Shoni Health Ventures.